New York City is a world-class metropolis and has been a center of innovation in the arts, sciences, business, and financial communities for decades. It continues to lead the way by supporting creative partnerships in life sciences and the biotech industry.
One of these new developments is located at The Rockefeller University, a leading research center. It will be the future home of the Stravos Niarchos Foundation-David Rockefeller River campus. These ongoing–and lucrative–partnerships have attracted the support of leaders in the financial community such as Chief Executive Officer Bill Ford of General Atlantic, who also serves a Vice Chairman at The Rockefeller University.
The Rockefeller University welcomed New York City Mayor Bill de Blasio in March to tour their campus and host a biotech conference. Wall Street has made New York City a center of international business for many years. Mayor de Blasio is working with life science industry leaders and educators in New York City to ensure that this region continues to be an important address for doing business today and in the future.
The biotech conference grew out of an interest in continuing the sustained growth of this sector in the region. Over the past five years the mayor’s office has been supporting policies that have created 15 percent growth in the city’s life science job market. The innovative policies have supported the construction of lab space that startups can afford to use. It has also encouraged entrepreneurship and supported programs that offer training and mentorship to life science companies launching new ventures.
The new campus will support the University’s goal of maintaining 75 independent laboratories. It will allow them to continue their groundbreaking research in biological imaging, cancer biology, immunotherapy, genetics, neuroscience, and other areas.
University president Marc Tessier-Lavigne spoke enthusiastically about the ongoing partnership between the university, the city, and the business community. “New York City has made significant progress in recent years in developing its commercial life-sciences industry,” he said. “Both Mayor de Blasio and Deputy Mayor Glen are committed to sustaining this growth and are working actively with industry leaders to help the bioscience sector reach its full potential.”
The future of life sciences and the biotech industry in New York City looks healthy today and for the foreseeable future.